What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
Dominique Elias focuses on Surgery, Colorectal cancer, Chemotherapy, Internal medicine and Hepatectomy.
The various areas that Dominique Elias examines in his Surgery study include Hyperthermic intraperitoneal chemotherapy and Metastasis.
The study incorporates disciplines such as Randomized controlled trial, Disease and Fluorouracil in addition to Colorectal cancer.
His Chemotherapy study combines topics in areas such as Cancer, Peritoneal cavity, Carcinosis, Peritoneal Cancer Index and Oxaliplatin.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Oncology.
His study in Hepatectomy is interdisciplinary in nature, drawing from both Mortality rate and Radiofrequency ablation.
His most cited work include:
- Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus (1161 citations)
- Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study (900 citations)
- Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value (697 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Surgery, Internal medicine, Chemotherapy, Colorectal cancer and Gastroenterology.
His Surgery research is multidisciplinary, incorporating elements of Hyperthermic intraperitoneal chemotherapy and Cancer, Metastasis.
His research in the fields of Surgical oncology, Retrospective cohort study and Adenocarcinoma overlaps with other disciplines such as In patient.
His Chemotherapy study combines topics from a wide range of disciplines, such as Carcinosis, Laparotomy, Perioperative and Oxaliplatin.
He combines subjects such as Prospective cohort study and Resection with his study of Colorectal cancer.
His research integrates issues of Muscle hypertrophy and Radiology in his study of Hepatectomy.
He most often published in these fields:
- Surgery (51.38%)
- Internal medicine (27.95%)
- Chemotherapy (25.98%)
What were the highlights of his more recent work (between 2010-2021)?
- Surgery (51.38%)
- Internal medicine (27.95%)
- Hyperthermic intraperitoneal chemotherapy (12.80%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Surgery, Internal medicine, Hyperthermic intraperitoneal chemotherapy, Colorectal cancer and Chemotherapy.
His work deals with themes such as Peritoneal Cancer Index and Cancer, which intersect with Surgery.
His biological study spans a wide range of topics, including Gastroenterology, Perioperative and Oncology.
His study looks at the relationship between Hyperthermic intraperitoneal chemotherapy and topics such as Peritoneal carcinomatosis, which overlap with Peritoneal cavity.
His research investigates the connection with Colorectal cancer and areas like Radiology which intersect with concerns in Lymph.
His Chemotherapy study combines topics in areas such as Neoadjuvant therapy, Carcinoembryonic antigen, Cohort and Stage.
Between 2010 and 2021, his most popular works were:
- Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value (697 citations)
- Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (611 citations)
- A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. (200 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Surgery, Internal medicine, Hyperthermic intraperitoneal chemotherapy, Chemotherapy and Colorectal cancer are his primary areas of study.
His Surgery research integrates issues from Cytoreductive surgery and Peritoneal Cancer Index.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Oncology.
The various areas that Dominique Elias examines in his Hyperthermic intraperitoneal chemotherapy study include Peritoneal carcinomatosis, Second Look Surgery, Perioperative, Carcinoma and Surgical oncology.
He has included themes like Neoadjuvant therapy, Carcinoembryonic antigen, Hepatic arterial infusion and Clinical endpoint in his Chemotherapy study.
His research in Colorectal cancer intersects with topics in Survival rate, Transforming growth factor, Randomized controlled trial and Cell polarity.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
